LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | CHIR-99021 | 0.37 | uM | LJP6 | 72 | hr | 1311 | 4269 | 4935 | 0.8651 | 0.8537 |
MDA-MB-231 | CHIR-99021 | 1.11 | uM | LJP6 | 72 | hr | 1311 | 4451 | 4935 | 0.9019 | 0.8949 |
MDA-MB-231 | CHIR-99021 | 3.33 | uM | LJP6 | 72 | hr | 1311 | 4289 | 4935 | 0.8695 | 0.8587 |
MDA-MB-231 | CHIR-99021 | 10 | uM | LJP6 | 72 | hr | 1311 | 3723 | 4935 | 0.7546 | 0.7258 |
MDA-MB-231 | Linifanib | 0.04 | uM | LJP6 | 72 | hr | 1311 | 5333 | 4935 | 1.0806 | 1.0826 |
MDA-MB-231 | Linifanib | 0.12 | uM | LJP6 | 72 | hr | 1311 | 5238 | 4935 | 1.0611 | 1.0623 |
MDA-MB-231 | Linifanib | 0.37 | uM | LJP6 | 72 | hr | 1311 | 5129 | 4935 | 1.0392 | 1.0406 |
MDA-MB-231 | Linifanib | 1.11 | uM | LJP6 | 72 | hr | 1311 | 5005 | 4935 | 1.0143 | 1.0146 |
MDA-MB-231 | Linifanib | 3.33 | uM | LJP6 | 72 | hr | 1311 | 4959 | 4935 | 1.0050 | 1.0049 |
MDA-MB-231 | Linifanib | 10 | uM | LJP6 | 72 | hr | 1311 | 2666 | 4935 | 0.5404 | 0.4493 |
MDA-MB-231 | PIK-93 | 0.04 | uM | LJP5 | 72 | hr | 1311 | 5214 | 5079 | 1.0265 | 1.0269 |
MDA-MB-231 | PIK-93 | 0.12 | uM | LJP5 | 72 | hr | 1311 | 5226 | 5079 | 1.0295 | 1.0296 |
MDA-MB-231 | PIK-93 | 0.37 | uM | LJP5 | 72 | hr | 1311 | 5165 | 5079 | 1.0171 | 1.0173 |
MDA-MB-231 | PIK-93 | 1.11 | uM | LJP5 | 72 | hr | 1311 | 4779 | 5079 | 0.9415 | 0.9387 |
MDA-MB-231 | PIK-93 | 3.33 | uM | LJP5 | 72 | hr | 1311 | 4073 | 5079 | 0.8023 | 0.7865 |
MDA-MB-231 | PIK-93 | 10 | uM | LJP5 | 72 | hr | 1311 | 2075 | 5079 | 0.4088 | 0.2647 |
MDA-MB-231 | Dactolisib | 0.04 | uM | LJP5 | 72 | hr | 1311 | 2836 | 5079 | 0.5586 | 0.4839 |
MDA-MB-231 | Dactolisib | 0.12 | uM | LJP5 | 72 | hr | 1311 | 2402 | 5079 | 0.4729 | 0.3630 |
MDA-MB-231 | Dactolisib | 0.37 | uM | LJP5 | 72 | hr | 1311 | 2036 | 5079 | 0.4010 | 0.2522 |
MDA-MB-231 | Dactolisib | 1.11 | uM | LJP5 | 72 | hr | 1311 | 2084 | 5079 | 0.4104 | 0.2670 |
MDA-MB-231 | Dactolisib | 3.33 | uM | LJP5 | 72 | hr | 1311 | 2071 | 5079 | 0.4077 | 0.2632 |
MDA-MB-231 | Dactolisib | 10 | uM | LJP5 | 72 | hr | 1311 | 2172 | 5079 | 0.4278 | 0.2945 |
MDA-MB-231 | Alpelisib | 0.04 | uM | LJP5 | 72 | hr | 1311 | 5183 | 5079 | 1.0207 | 1.0211 |
MDA-MB-231 | Alpelisib | 0.12 | uM | LJP5 | 72 | hr | 1311 | 5184 | 5079 | 1.0208 | 1.0208 |
MDA-MB-231 | Alpelisib | 0.37 | uM | LJP5 | 72 | hr | 1311 | 4992 | 5079 | 0.9829 | 0.9816 |